Australia markets closed

GLOBALFOUNDRIES Inc. (GFS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
48.65+0.86 (+1.80%)
As of 12:33PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 26.44B
Enterprise value 25.39B
Trailing P/E 26.11
Forward P/E 27.55
PEG ratio (5-yr expected) 1.44
Price/sales (ttm)3.59
Price/book (mrq)2.38
Enterprise value/revenue 3.43
Enterprise value/EBITDA 9.58

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-18.72%
S&P500 52-week change 321.08%
52-week high 368.57
52-week low 345.52
50-day moving average 351.56
200-day moving average 355.60

Share statistics

Avg vol (3-month) 31.61M
Avg vol (10-day) 31.55M
Shares outstanding 5553.2M
Implied shares outstanding 6573.13M
Float 883.6M
% held by insiders 10.00%
% held by institutions 1102.63%
Shares short (15 Apr 2024) 413.34M
Short ratio (15 Apr 2024) 410.6
Short % of float (15 Apr 2024) 415.94%
Short % of shares outstanding (15 Apr 2024) 42.41%
Shares short (prior month 15 Mar 2024) 412.55M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.80%
Operating margin (ttm)17.96%

Management effectiveness

Return on assets (ttm)4.18%
Return on equity (ttm)9.64%

Income statement

Revenue (ttm)7.39B
Revenue per share (ttm)13.39
Quarterly revenue growth (yoy)-11.80%
Gross profit (ttm)N/A
EBITDA 2.65B
Net income avi to common (ttm)1.02B
Diluted EPS (ttm)1.83
Quarterly earnings growth (yoy)-58.50%

Balance sheet

Total cash (mrq)3.42B
Total cash per share (mrq)6.18
Total debt (mrq)2.37B
Total debt/equity (mrq)21.27%
Current ratio (mrq)2.04
Book value per share (mrq)20.08

Cash flow statement

Operating cash flow (ttm)2.12B
Levered free cash flow (ttm)-48M